Jean‐Jacques Tuech

Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability

Bernhard Mlecnik, Gabriela Bindea, Helen K. Angell et al. · Immunity · 2016 · 1K citations · Full text

Tumor Biology, Medicine, Immunology +9

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

Frédéric Di Fiore, Frédéric Blanchard, F. Charbonnier et al. · British Journal of Cancer · 2007 · 733 citations · Full text

Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)

Jérémie H. Lefèvre, Laurent Mineur, Salma Kotti et al. · Journal of Clinical Oncology · 2016 · 462 citations

Rectal Tumor, Surgical Oncology, Health Sciences +15

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial

Éric Rullier, Philippe Rouanet, Jean‐Jacques Tuech et al. · The Lancet · 2017 · 366 citations

Gastrointestinal Oncology, Greccar 2, Colorectal Surgery +8

Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy

Pauline Maby, David Tougeron, Mohamad Hamieh et al. · Cancer Research · 2015 · 240 citations

Genetics, Cd8+ T-cell Infiltrate, Immunology +17